
Data companies band together to form RWE Alliance
Can an industry coalition help craft policy to support the use of Real-World Evidence? Five prominent real-world data and analytics companies are betting on it, launching the RWE Alliance.
Can an industry coalition help craft policy to support the use of Real-World Evidence? Five prominent real-world data and analytics companies are betting on it, launching the RWE Alliance.
In the panel "The Data Problem in Scaling Artificial Intelligence in Healthcare" at the recent MedCity CONVERGE conference, experts from big pharma and health tech discussed challenges in scaling AI such as data gaps and navigating the potential ethical pitfalls of democratizing data.
In a panel discussion at the MedCity CONVERGE conference exploring the opportunities and challenges posed by the data underpinning AI tools, panelists representing big pharma, health tech and clinical data network shared some of their insights.
Health tech applications in the realm of cancer treatment will be a major theme of the CONVERGE conference in Philadelphia June 19 in Philadelphia, from improving the patient experience to AI. Register now!
Data published in JAMA on lung cancer patients treated with immunotherapy drugs, gleaned from EHRs and genomic sequencing, backs up clinical trial data and validates clinico-genomic database, the companies said.
Gottlieb, who is expected to step down in about a month, leaves behind a unique legacy and will likely be difficult to replace.
The collaboration, which started back in 2016, has focused on how real-world evidence derived from EHRs can support regulatory decision-making.
With the approval of Loxo's Vitrakvi, pan-cancer drugs and an emphasis on real-world data are likely to become important trends trends this year.
Oncologist Amy Abernethy, who currently serves as Flatiron's chief medical officer, chief scientific officer and senior vice president of oncology, will join the agency in the next few months.
Merck and Palantir Technologies are forming a joint research venture called Syntropy as a way to offer data analytics tools to healthcare organizations.
Pharmaceutical giant Roche will buy New York City-based startup Flatiron Health. The Swiss company led Flatiron's $175 million Series C round. The deal is expected to close in the first half of this year.
In a new analysis, Accenture dives deeper into digital health funding. The assessment includes a prediction that annual investment in digital health startups will reach $7 billion by the end of 2017.
Which in vitro diagnostics are filling providers’ needs? Are they deficient in a performance characteristic that your IVD will improve upon or have you developed a new method that is more cost-efficient?
EHRs don't always get the most love from providers. But with its OncoEMR, New York City-based startup Flatiron Health is rethinking the concept of an EHR and everything it encompasses.
The panel discussion at the Association of Community Cancer Centers highlighted some of the inherent challenges in doing clinical trials and ways to work towards overcoming them.